<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Tryparsamide </italic>started to be used in the mid-1920s, and was administered in series of weekly intravenous injections (with varying regimens). HAT campaigns peaked earlier than syphilis and yaws treatments, 
 <italic>i.e.</italic>, nearer to the calculated tMRCAs of HIV-1 groups M and O [
 <xref ref-type="bibr" rid="B26-viruses-04-01950">26</xref>,
 <xref ref-type="bibr" rid="B27-viruses-04-01950">27</xref>,
 <xref ref-type="bibr" rid="B28-viruses-04-01950">28</xref>,
 <xref ref-type="bibr" rid="B29-viruses-04-01950">29</xref>,
 <xref ref-type="bibr" rid="B30-viruses-04-01950">30</xref>]. In Cameroon, they had a sharp peak in 1926–1928 (
 <xref ref-type="fig" rid="viruses-04-01950-f002">Figure 2</xref>), when Eugene Jamot started more organized campaigns based on mobile teams that visited most of the population [
 <xref ref-type="bibr" rid="B50-viruses-04-01950">50</xref>,
 <xref ref-type="bibr" rid="B115-viruses-04-01950">115</xref>,
 <xref ref-type="bibr" rid="B116-viruses-04-01950">116</xref>,
 <xref ref-type="bibr" rid="B117-viruses-04-01950">117</xref>,
 <xref ref-type="bibr" rid="B118-viruses-04-01950">118</xref>]. A few years later, similar teams were put in place in AEF [
 <xref ref-type="bibr" rid="B72-viruses-04-01950">72</xref>,
 <xref ref-type="bibr" rid="B119-viruses-04-01950">119</xref>]. Review articles about these organized campaigns of French Cameroon and AEF show that each patient received 15–24 injections, spread over a period of treatment of two or more years. More than half of the injections were of the cheaper and non-intravenous 
 <italic>atoxyl </italic>[
 <xref ref-type="bibr" rid="B115-viruses-04-01950">115</xref>,
 <xref ref-type="bibr" rid="B116-viruses-04-01950">116</xref>,
 <xref ref-type="bibr" rid="B120-viruses-04-01950">120</xref>]. 
</p>
